JP2007530121A - 遺伝子治療 - Google Patents
遺伝子治療 Download PDFInfo
- Publication number
- JP2007530121A JP2007530121A JP2007504488A JP2007504488A JP2007530121A JP 2007530121 A JP2007530121 A JP 2007530121A JP 2007504488 A JP2007504488 A JP 2007504488A JP 2007504488 A JP2007504488 A JP 2007504488A JP 2007530121 A JP2007530121 A JP 2007530121A
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- catheter
- body part
- pressure
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001415 gene therapy Methods 0.000 title claims description 25
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 79
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 78
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 78
- 238000000034 method Methods 0.000 claims abstract description 45
- 239000012530 fluid Substances 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 16
- 241001465754 Metazoa Species 0.000 claims abstract description 14
- 241000282414 Homo sapiens Species 0.000 claims abstract description 8
- 238000004891 communication Methods 0.000 claims abstract description 6
- 210000004185 liver Anatomy 0.000 claims description 38
- 239000013612 plasmid Substances 0.000 claims description 28
- 239000007924 injection Substances 0.000 claims description 19
- 238000002347 injection Methods 0.000 claims description 19
- 210000002216 heart Anatomy 0.000 claims description 18
- 210000000056 organ Anatomy 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 238000009472 formulation Methods 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 7
- 210000000952 spleen Anatomy 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 3
- 210000003734 kidney Anatomy 0.000 claims description 3
- 210000000496 pancreas Anatomy 0.000 claims description 3
- 210000004100 adrenal gland Anatomy 0.000 claims description 2
- 210000004072 lung Anatomy 0.000 claims description 2
- 210000001672 ovary Anatomy 0.000 claims description 2
- 210000002307 prostate Anatomy 0.000 claims description 2
- 210000002784 stomach Anatomy 0.000 claims description 2
- 230000000903 blocking effect Effects 0.000 abstract 1
- 210000002989 hepatic vein Anatomy 0.000 description 28
- 210000004027 cell Anatomy 0.000 description 25
- 210000003494 hepatocyte Anatomy 0.000 description 21
- 210000003462 vein Anatomy 0.000 description 17
- 102000036693 Thrombopoietin Human genes 0.000 description 16
- 108010041111 Thrombopoietin Proteins 0.000 description 16
- 238000001890 transfection Methods 0.000 description 16
- 238000011282 treatment Methods 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
- 239000013598 vector Substances 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 11
- 239000011780 sodium chloride Substances 0.000 description 10
- 241000282887 Suidae Species 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 238000001802 infusion Methods 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 238000002604 ultrasonography Methods 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 239000004952 Polyamide Substances 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000007449 liver function test Methods 0.000 description 5
- 229920002647 polyamide Polymers 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 239000013603 viral vector Substances 0.000 description 5
- 241000282412 Homo Species 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000004731 jugular vein Anatomy 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000001174 ascending effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000009534 blood test Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 241000713666 Lentivirus Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000001919 adrenal effect Effects 0.000 description 2
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 2
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 238000010876 biochemical test Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004820 blood count Methods 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- 210000003748 coronary sinus Anatomy 0.000 description 2
- 238000002716 delivery method Methods 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000001105 femoral artery Anatomy 0.000 description 2
- 230000002489 hematologic effect Effects 0.000 description 2
- 210000002767 hepatic artery Anatomy 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 210000003593 megakaryocyte Anatomy 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001839 systemic circulation Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- 210000001631 vena cava inferior Anatomy 0.000 description 2
- KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 241000702421 Dependoparvovirus Species 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 101000799461 Homo sapiens Thrombopoietin Proteins 0.000 description 1
- 101000694103 Homo sapiens Thyroid peroxidase Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 101000694118 Rattus norvegicus Thyroid peroxidase Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 208000037919 acquired disease Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 108700004025 env Genes Proteins 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- -1 for example Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229940005494 general anesthetics Drugs 0.000 description 1
- 230000004077 genetic alteration Effects 0.000 description 1
- 231100000118 genetic alteration Toxicity 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 102000053400 human TPO Human genes 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000002601 intratumoral effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 101150066555 lacZ gene Proteins 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 230000003582 thrombocytopenic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 210000005167 vascular cell Anatomy 0.000 description 1
- 210000002620 vena cava superior Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Child & Adolescent Psychology (AREA)
- Pulmonology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0406728.6A GB0406728D0 (en) | 2004-03-25 | 2004-03-25 | Gene therapy |
| PCT/GB2005/001243 WO2005092425A1 (en) | 2004-03-25 | 2005-03-29 | Gene |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007530121A true JP2007530121A (ja) | 2007-11-01 |
| JP2007530121A5 JP2007530121A5 (https=) | 2008-05-15 |
Family
ID=32188684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007504488A Pending JP2007530121A (ja) | 2004-03-25 | 2005-03-29 | 遺伝子治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20080097384A1 (https=) |
| EP (1) | EP1727589A1 (https=) |
| JP (1) | JP2007530121A (https=) |
| CN (1) | CN1933868A (https=) |
| AU (1) | AU2005225211A1 (https=) |
| GB (1) | GB0406728D0 (https=) |
| WO (1) | WO2005092425A1 (https=) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012531896A (ja) * | 2009-06-29 | 2012-12-13 | チェン,チンフェン | ヒト化非ヒト哺乳動物を製造する方法 |
| JP2014507986A (ja) * | 2011-01-25 | 2014-04-03 | インビジョン メディカル コーポレイション | 狭小身体内腔を維持するためのシステムおよび方法 |
| JP2015513528A (ja) * | 2012-02-07 | 2015-05-14 | グローバル・バイオ・セラピューティクス・ユーエスエイ・インコーポレイテッドGlobal Bio Therapeutics,Usa,Inc. | 核酸送達の区画化方法ならびにその組成物および使用 |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070173470A1 (en) * | 2006-01-23 | 2007-07-26 | Chi-Hung Lin | Methods for delivering extracellular target into cells |
| JP4696247B2 (ja) * | 2006-12-11 | 2011-06-08 | 国立大学法人 筑波大学 | 肝線維化抑制剤 |
| CA2917047C (en) | 2013-08-30 | 2019-06-11 | Hollister Incorporated | Device for trans-anal irrigation |
| AU2015287989C1 (en) * | 2014-07-08 | 2020-07-02 | Hollister Incorporated | Portable trans anal irrigation device |
| EP3166662B1 (en) | 2014-07-08 | 2023-06-07 | Hollister Incorporated | Trans anal irrigation platform with bed module |
| LT3481460T (lt) | 2016-07-08 | 2020-07-27 | Hollister Incorporated | Bevielis elektroninis siurblys, skirtas kūno ertmės irigacijos aparatui |
| EP3777921B1 (en) | 2016-12-14 | 2025-08-13 | Hollister Incorporated | Transanal irrigation system |
| US20230100660A1 (en) * | 2021-09-24 | 2023-03-30 | Gyrus Acmi, Inc. | Devices, systems, and methods for occluding and allowing fluid access to occlused area |
| CA3265882A1 (en) * | 2022-08-31 | 2024-03-07 | Hydrogene Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR HYDRODYNAMIC GENE ADMINISTRATION |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5922687A (en) * | 1995-05-04 | 1999-07-13 | Board Of Trustees Of The Leland Stanford Junior University | Intracellular delivery of nucleic acids using pressure |
| US6494861B1 (en) * | 1997-01-15 | 2002-12-17 | Boston Scientific Corporation | Drug delivery system |
| JP2004503340A (ja) * | 2000-07-13 | 2004-02-05 | エドワーズ ライフサイエンシーズ コーポレイション | 脈管形成のための複数バルーン薬剤送達カテーテル |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5069662A (en) * | 1988-10-21 | 1991-12-03 | Delcath Systems, Inc. | Cancer treatment |
| US5328470A (en) * | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| US5698531A (en) * | 1989-03-31 | 1997-12-16 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| US20020001574A1 (en) * | 1995-12-13 | 2002-01-03 | Jon A. Woiff | Process of delivering a polynucleotide to a muscle cell via the vascular system |
| EP1024832A1 (en) * | 1997-10-24 | 2000-08-09 | Children's Medical Center Corporation | METHODS FOR PROMOTING CELL TRANSFECTION $i(IN VIVO) |
| US6290689B1 (en) * | 1999-10-22 | 2001-09-18 | Corazón Technologies, Inc. | Catheter devices and methods for their use in the treatment of calcified vascular occlusions |
| US7015040B2 (en) * | 1999-02-26 | 2006-03-21 | Mirus Bio Corporation | Intravascular delivery of nucleic acid |
| JP2004337400A (ja) * | 2003-05-16 | 2004-12-02 | Terumo Corp | 薬剤投与キット |
-
2004
- 2004-03-25 GB GBGB0406728.6A patent/GB0406728D0/en not_active Ceased
-
2005
- 2005-03-29 AU AU2005225211A patent/AU2005225211A1/en not_active Abandoned
- 2005-03-29 EP EP05732486A patent/EP1727589A1/en not_active Withdrawn
- 2005-03-29 US US10/594,099 patent/US20080097384A1/en not_active Abandoned
- 2005-03-29 CN CNA2005800094807A patent/CN1933868A/zh active Pending
- 2005-03-29 JP JP2007504488A patent/JP2007530121A/ja active Pending
- 2005-03-29 WO PCT/GB2005/001243 patent/WO2005092425A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5922687A (en) * | 1995-05-04 | 1999-07-13 | Board Of Trustees Of The Leland Stanford Junior University | Intracellular delivery of nucleic acids using pressure |
| US6494861B1 (en) * | 1997-01-15 | 2002-12-17 | Boston Scientific Corporation | Drug delivery system |
| JP2004503340A (ja) * | 2000-07-13 | 2004-02-05 | エドワーズ ライフサイエンシーズ コーポレイション | 脈管形成のための複数バルーン薬剤送達カテーテル |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012531896A (ja) * | 2009-06-29 | 2012-12-13 | チェン,チンフェン | ヒト化非ヒト哺乳動物を製造する方法 |
| JP2014507986A (ja) * | 2011-01-25 | 2014-04-03 | インビジョン メディカル コーポレイション | 狭小身体内腔を維持するためのシステムおよび方法 |
| US10610149B2 (en) | 2011-01-25 | 2020-04-07 | Boston Scientific Scimed, Inc. | Systems and methods for maintaining a narrow body lumen |
| JP2015513528A (ja) * | 2012-02-07 | 2015-05-14 | グローバル・バイオ・セラピューティクス・ユーエスエイ・インコーポレイテッドGlobal Bio Therapeutics,Usa,Inc. | 核酸送達の区画化方法ならびにその組成物および使用 |
| US9821114B2 (en) | 2012-02-07 | 2017-11-21 | Global Bio Therapeutics, Inc. | Compartmentalized method of nucleic acid delivery and compositions and uses thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1727589A1 (en) | 2006-12-06 |
| WO2005092425A1 (en) | 2005-10-06 |
| AU2005225211A1 (en) | 2005-10-06 |
| US20080097384A1 (en) | 2008-04-24 |
| GB0406728D0 (en) | 2004-04-28 |
| CN1933868A (zh) | 2007-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2297080C (en) | Novel apparatus and method for isolated pelvic perfusion | |
| JP7777202B2 (ja) | 生物学的療法またはベクター遺伝子療法における左心室の負荷を軽減するためのシステムおよび方法 | |
| US7297475B2 (en) | Medicament injection kit and medicament injection method | |
| US20060135940A1 (en) | Programmed pulsed infusion methods and devices | |
| US20060258980A1 (en) | Global myocardial perfusion catheter | |
| WO1999011316A1 (en) | Novel apparatus and method of treating a tumor in the extremity of a patient | |
| JPH11514366A (ja) | 虚血組織を処置するための方法 | |
| KR20150016970A (ko) | 세포 치료요법에 유용한 카테터 시스템 및 방법 | |
| US9675673B2 (en) | Transluminal delivery of oncoltyic viruses for cancer therapy | |
| WO1999002202A2 (en) | Catheter with slidable balloon | |
| JP2007530121A (ja) | 遺伝子治療 | |
| WO2015050154A1 (ja) | 膵灌流装置,その制御方法及び膵灌流方法 | |
| TW202302173A (zh) | 肝之局部區域(loco-regional)灌流 | |
| JP2019515011A (ja) | 肝臓組織を処置するための方法 | |
| CN103599588A (zh) | 呈现迅速膨胀和收缩的改进型球囊导管 | |
| CN117179844B (zh) | 一种封堵治疗血管病变和恶性肿瘤的装置 | |
| Kruse et al. | Endoscopic-mediated, biliary hydrodynamic injection mediating clinically relevant levels of gene delivery in pig liver | |
| CN117045944A (zh) | 一种球囊输送装置 | |
| JP4977340B2 (ja) | 傍大動脈リンパ節腫瘍への薬剤灌流設備 | |
| CN117241855A (zh) | 肝脏的局部区域灌注 | |
| US20060015065A1 (en) | Method of drug perfusion in paraaortic lymph node tumors, sheath for inserting catheter, and oxygenated blood perfusion apparatus | |
| TWI221422B (en) | Quasi-T shaped catheter for chemotherapy | |
| US11583662B2 (en) | Methods and compositions for consistent intracoronary administration of a biologic | |
| JP2005152317A (ja) | 薬剤投与用カテーテル | |
| JPS62155861A (ja) | 治療装置 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080328 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080328 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100629 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101130 |